Advertisement

Reactions Weekly

, Volume 1713, Issue 1, pp 178–178 | Cite as

Gemcitabine/oxaliplatin/pegaspargase

Various toxicities: 2 case reports
Case report
  • 49 Downloads

Reference

  1. Neumann DR, et al. Pegasparaginase silent inactivation during therapy for NK/T cell lymphoma. Leukemia and Lymphoma 59: 1596-1605, No. 7, 2018. Available from: URL: http://doi.org/10.1080/10428194.2017.1393672 - USA

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations